MoreinX

MoreinX is a Swedish biotechnology company focused on the development of advanced vaccine adjuvants and delivery systems. Leveraging the pioneering research of Professor Bror Morein, the company specializes in Immune Stimulating Complex (ISCOM) technology, which utilizes nanoparticle-based formulations to enhance both humoral and cellular immune responses. MoreinX's proprietary platform is designed to improve the efficacy and stability of vaccines across various therapeutic areas, including infectious diseases and cancer immunotherapy. The company operates primarily as a technology provider and collaborator, offering its specialized adjuvant expertise to partners in the human and veterinary vaccine sectors.